Selected research
Market Structure
Global Mice Model Genetic Engineering Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Mice Model Genetic Engineering market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Mice Model Genetic Engineering is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Mice Model Genetic Engineering is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Mice Model Genetic Engineering is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Mice Model Genetic Engineering is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Mice Model Genetic Engineering include B BIOCYTOGEN, Charles River Laboratories, Cyagen Biosciences, Gempharmatech, genOway, ingenious targeting laboratory, Ozgene Pty Ltd., Taconic Biosciences, Inc. and PolyGene AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Mice Model Genetic Engineering market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Mice Model Genetic Engineering and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Mice Model Genetic Engineering revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Mice Model Genetic Engineering market size, projected growth trends, production technologies, key applications, and end-use industries.
Mice Model Genetic Engineering Segment by Company
B BIOCYTOGEN
Charles River Laboratories
Cyagen Biosciences
Gempharmatech
genOway
ingenious targeting laboratory
Ozgene Pty Ltd.
Taconic Biosciences, Inc.
PolyGene AG
THE JACKSON LABORATORY
Yale School of Medicine
University of North Carolina
University of Nebraska Medical Center
Monash University
UMass Chan Medical School
University of Bonn
Columbia University
The University of Arizona
The Weizmann Institute of Science
The Hebrew University of Jerusalem
The Technion – Israel Institute of Technology
Hadassah BrainLabs
Mice Model Genetic Engineering Segment by Type
CRISPR Knockout
CRISPR Knockin
Random Insertions
ES Cell Modification (homologous recombination)
Others
Mice Model Genetic Engineering Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic & Research Facilities
Contract Research & Manufacturing Organizations
Mice Model Genetic Engineering Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mice Model Genetic Engineering market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mice Model Genetic Engineering and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mice Model Genetic Engineering.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Mice Model Genetic Engineering in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mice Model Genetic Engineering industry.
Chapter 3: Detailed analysis of Mice Model Genetic Engineering companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mice Model Genetic Engineeringrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
List of Tables
Table 1. Global Mice Model Genetic Engineering Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032
Table 2. Key Players of CRISPR Knockout
Table 3. Key Players of CRISPR Knockin
Table 4. Key Players of Random Insertions
Table 3. Key Players of ES Cell Modification (homologous recombination)
Table 4. Key Players of Others
Table 5. Global Mice Model Genetic Engineering Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032
Table 6. Key Players of Pharmaceutical Companies
Table 7. Key Players of Biotechnology Companies
Table 8. Key Players of Academic & Research Facilities
Table 9. Key Players of Contract Research & Manufacturing Organizations
Table 10. Global Mice Model Genetic Engineering Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032
Table 11. Global Mice Model Genetic Engineering Market Size by Region (2021-2026) & (US$ Million)
Table 12. Global Mice Model Genetic Engineering Market Share by Region (2021-2026)
Table 13. Global Mice Model Genetic Engineering Market Size by Region (2027-2032) & (US$ Million)
Table 14. Global Mice Model Genetic Engineering Market Share by Region (2027-2032)
Table 15. Mice Model Genetic Engineering Industry Trends
Table 16. Mice Model Genetic Engineering Industry Drivers
Table 17. Mice Model Genetic Engineering Industry Opportunities and Challenges
Table 18. Mice Model Genetic Engineering Industry Restraints
Table 19. Global Mice Model Genetic Engineering Revenue by Company (US$ Million) & (2021-2026)
Table 20. Global Mice Model Genetic Engineering Revenue Market Share by Company (2021-2026)
Table 21. Global Mice Model Genetic Engineering Players Revenue Ranking, 2024 VS 2025 VS 2026
Table 22. Global Mice Model Genetic Engineering Key Company Head Office and Area Served
Table 23. Global Mice Model Genetic Engineering Company, Product Type & Application
Table 24. Global Mice Model Genetic Engineering Company Establishment Date
Table 25. Global Company Market Concentration Ratio (CR5 and HHI)
Table 26. Global Mice Model Genetic Engineering by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025)
Table 27. Global Mice Model Genetic Engineering Market Size by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 28. Global Mice Model Genetic Engineering Market Size by Type (2021-2026) & (US$ Million)
Table 29. Global Mice Model Genetic Engineering Market Size by Type (2027-2032) & (US$ Million)
Table 30. Global Mice Model Genetic Engineering Revenue Market Share by Type (2021-2026)
Table 31. Global Mice Model Genetic Engineering Revenue Market Share by Type (2027-2032)
Table 32. Global Mice Model Genetic Engineering Market Size by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 33. Global Mice Model Genetic Engineering Market Size by Application (2021-2026) & (US$ Million)
Table 34. Global Mice Model Genetic Engineering Market Size by Application (2027-2032) & (US$ Million)
Table 35. Global Mice Model Genetic Engineering Revenue Market Share by Application (2021-2026)
Table 36. Global Mice Model Genetic Engineering Revenue Market Share by Application (2027-2032)
Table 37. B BIOCYTOGEN Company Information
Table 38. B BIOCYTOGEN Business Overview
Table 39. B BIOCYTOGEN Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 40. B BIOCYTOGEN Mice Model Genetic Engineering Product Portfolio
Table 41. B BIOCYTOGEN Recent Development
Table 42. Charles River Laboratories Company Information
Table 43. Charles River Laboratories Business Overview
Table 44. Charles River Laboratories Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 45. Charles River Laboratories Mice Model Genetic Engineering Product Portfolio
Table 46. Charles River Laboratories Recent Development
Table 47. Cyagen Biosciences Company Information
Table 48. Cyagen Biosciences Business Overview
Table 49. Cyagen Biosciences Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 50. Cyagen Biosciences Mice Model Genetic Engineering Product Portfolio
Table 51. Cyagen Biosciences Recent Development
Table 52. Gempharmatech Company Information
Table 53. Gempharmatech Business Overview
Table 54. Gempharmatech Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 55. Gempharmatech Mice Model Genetic Engineering Product Portfolio
Table 56. Gempharmatech Recent Development
Table 57. genOway Company Information
Table 58. genOway Business Overview
Table 59. genOway Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 60. genOway Mice Model Genetic Engineering Product Portfolio
Table 61. genOway Recent Development
Table 62. ingenious targeting laboratory Company Information
Table 63. ingenious targeting laboratory Business Overview
Table 64. ingenious targeting laboratory Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 65. ingenious targeting laboratory Mice Model Genetic Engineering Product Portfolio
Table 66. ingenious targeting laboratory Recent Development
Table 67. Ozgene Pty Ltd. Company Information
Table 68. Ozgene Pty Ltd. Business Overview
Table 69. Ozgene Pty Ltd. Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 70. Ozgene Pty Ltd. Mice Model Genetic Engineering Product Portfolio
Table 71. Ozgene Pty Ltd. Recent Development
Table 72. Taconic Biosciences, Inc. Company Information
Table 73. Taconic Biosciences, Inc. Business Overview
Table 74. Taconic Biosciences, Inc. Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 75. Taconic Biosciences, Inc. Mice Model Genetic Engineering Product Portfolio
Table 76. Taconic Biosciences, Inc. Recent Development
Table 77. PolyGene AG Company Information
Table 78. PolyGene AG Business Overview
Table 79. PolyGene AG Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 80. PolyGene AG Mice Model Genetic Engineering Product Portfolio
Table 81. PolyGene AG Recent Development
Table 82. THE JACKSON LABORATORY Company Information
Table 83. THE JACKSON LABORATORY Business Overview
Table 84. THE JACKSON LABORATORY Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 85. THE JACKSON LABORATORY Mice Model Genetic Engineering Product Portfolio
Table 86. THE JACKSON LABORATORY Recent Development
Table 87. Yale School of Medicine Company Information
Table 88. Yale School of Medicine Business Overview
Table 89. Yale School of Medicine Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 90. Yale School of Medicine Mice Model Genetic Engineering Product Portfolio
Table 91. Yale School of Medicine Recent Development
Table 92. University of North Carolina Company Information
Table 93. University of North Carolina Business Overview
Table 94. University of North Carolina Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 95. University of North Carolina Mice Model Genetic Engineering Product Portfolio
Table 96. University of North Carolina Recent Development
Table 97. University of Nebraska Medical Center Company Information
Table 98. University of Nebraska Medical Center Business Overview
Table 99. University of Nebraska Medical Center Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 100. University of Nebraska Medical Center Mice Model Genetic Engineering Product Portfolio
Table 101. University of Nebraska Medical Center Recent Development
Table 102. Monash University Company Information
Table 103. Monash University Business Overview
Table 104. Monash University Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 105. Monash University Mice Model Genetic Engineering Product Portfolio
Table 106. Monash University Recent Development
Table 107. UMass Chan Medical School Company Information
Table 108. UMass Chan Medical School Business Overview
Table 109. UMass Chan Medical School Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 110. UMass Chan Medical School Mice Model Genetic Engineering Product Portfolio
Table 111. UMass Chan Medical School Recent Development
Table 112. University of Bonn Company Information
Table 113. University of Bonn Business Overview
Table 114. University of Bonn Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 115. University of Bonn Mice Model Genetic Engineering Product Portfolio
Table 116. University of Bonn Recent Development
Table 117. Columbia University Company Information
Table 118. Columbia University Business Overview
Table 119. Columbia University Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 120. Columbia University Mice Model Genetic Engineering Product Portfolio
Table 121. Columbia University Recent Development
Table 122. The University of Arizona Company Information
Table 123. The University of Arizona Business Overview
Table 124. The University of Arizona Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 125. The University of Arizona Mice Model Genetic Engineering Product Portfolio
Table 126. The University of Arizona Recent Development
Table 127. The Weizmann Institute of Science Company Information
Table 128. The Weizmann Institute of Science Business Overview
Table 129. The Weizmann Institute of Science Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 130. The Weizmann Institute of Science Mice Model Genetic Engineering Product Portfolio
Table 131. The Weizmann Institute of Science Recent Development
Table 132. The Hebrew University of Jerusalem Company Information
Table 133. The Hebrew University of Jerusalem Business Overview
Table 134. The Hebrew University of Jerusalem Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 135. The Hebrew University of Jerusalem Mice Model Genetic Engineering Product Portfolio
Table 136. The Hebrew University of Jerusalem Recent Development
Table 137. The Technion – Israel Institute of Technology Company Information
Table 138. The Technion – Israel Institute of Technology Business Overview
Table 139. The Technion – Israel Institute of Technology Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 140. The Technion – Israel Institute of Technology Mice Model Genetic Engineering Product Portfolio
Table 141. The Technion – Israel Institute of Technology Recent Development
Table 142. Hadassah BrainLabs Company Information
Table 143. Hadassah BrainLabs Business Overview
Table 144. Hadassah BrainLabs Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 145. Hadassah BrainLabs Mice Model Genetic Engineering Product Portfolio
Table 146. Hadassah BrainLabs Recent Development
Table 147. North America Mice Model Genetic Engineering Market Size by Type (2021-2026) & (US$ Million)
Table 148. North America Mice Model Genetic Engineering Market Size by Type (2027-2032) & (US$ Million)
Table 149. North America Mice Model Genetic Engineering Market Size by Application (2021-2026) & (US$ Million)
Table 150. North America Mice Model Genetic Engineering Market Size by Application (2027-2032) & (US$ Million)
Table 151. North America Mice Model Genetic Engineering Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 152. North America Mice Model Genetic Engineering Market Size by Country (2021-2026)
Table 153. North America Mice Model Genetic Engineering Market Size by Country (2027-2032)
Table 154. Europe Mice Model Genetic Engineering Market Size by Type (2021-2026) & (US$ Million)
Table 155. Europe Mice Model Genetic Engineering Market Size by Type (2027-2032) & (US$ Million)
Table 156. Europe Mice Model Genetic Engineering Market Size by Application (2021-2026) & (US$ Million)
Table 157. Europe Mice Model Genetic Engineering Market Size by Application (2027-2032) & (US$ Million)
Table 158. Europe Mice Model Genetic Engineering Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 159. Europe Mice Model Genetic Engineering Market Size by Country (2021-2026)
Table 160. Europe Mice Model Genetic Engineering Market Size by Country (2027-2032)
Table 161. China Mice Model Genetic Engineering Market Size by Type (2021-2026) & (US$ Million)
Table 162. China Mice Model Genetic Engineering Market Size by Type (2027-2032) & (US$ Million)
Table 163. China Mice Model Genetic Engineering Market Size by Application (2021-2026) & (US$ Million)
Table 164. China Mice Model Genetic Engineering Market Size by Application (2027-2032) & (US$ Million)
Table 165. Asia Mice Model Genetic Engineering Market Size by Type (2021-2026) & (US$ Million)
Table 166. Asia Mice Model Genetic Engineering Market Size by Type (2027-2032) & (US$ Million)
Table 167. Asia Mice Model Genetic Engineering Market Size by Application (2021-2026) & (US$ Million)
Table 168. Asia Mice Model Genetic Engineering Market Size by Application (2027-2032) & (US$ Million)
Table 169. Asia Mice Model Genetic Engineering Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 170. Asia Mice Model Genetic Engineering Market Size by Country (2021-2026)
Table 171. Asia Mice Model Genetic Engineering Market Size by Country (2027-2032)
Table 172. South America, Middle East & Africa Mice Model Genetic Engineering Market Size by Type (2021-2026) & (US$ Million)
Table 173. South America, Middle East & Africa Mice Model Genetic Engineering Market Size by Type (2027-2032) & (US$ Million)
Table 174. South America, Middle East & Africa Mice Model Genetic Engineering Market Size by Application (2021-2026) & (US$ Million)
Table 175. South America, Middle East & Africa Mice Model Genetic Engineering Market Size by Application (2027-2032) & (US$ Million)
Table 176. South America, Middle East & Africa Mice Model Genetic Engineering Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 177. South America, Middle East & Africa Mice Model Genetic Engineering Market Size by Country (2021-2026)
Table 178. South America, Middle East & Africa Mice Model Genetic Engineering Market Size by Country (2027-2032)
Table 179. Research Programs/Design for This Report
Table 180. Authors List of This Report
Table 181. Secondary Sources
Table 182. Primary Sources
List of Figures
Figure 1. Mice Model Genetic Engineering Product Image
Figure 2. Global Mice Model Genetic Engineering Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million)
Figure 3. Global Mice Model Genetic Engineering Market Share by Type: 2025 VS 2032
Figure 4. CRISPR Knockout Image
Figure 5. CRISPR Knockin Image
Figure 6. Random Insertions Image
Figure 7. ES Cell Modification (homologous recombination) Image
Figure 8. Others Image
Figure 9. Global Mice Model Genetic Engineering Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million)
Figure 10. Global Mice Model Genetic Engineering Market Share by Application: 2025 VS 2032
Figure 11. Pharmaceutical Companies Image
Figure 12. Biotechnology Companies Image
Figure 13. Academic & Research Facilities Image
Figure 14. Contract Research & Manufacturing Organizations Image
Figure 15. Global Mice Model Genetic Engineering Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 16. Global Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 17. Global Mice Model Genetic Engineering Market Share by Region: 2025 VS 2032
Figure 18. Years Considered
Figure 19. Global Mice Model Genetic Engineering Market Share by Players in 2025
Figure 20. Global Top 5 and 10 Mice Model Genetic Engineering Players Market Share by Revenue in 2025
Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 22. Global Mice Model Genetic Engineering Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 23. Global Mice Model Genetic Engineering Revenue Market Share by Type (2021-2032)
Figure 24. Global Mice Model Genetic Engineering Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 25. Global Mice Model Genetic Engineering Revenue Market Share by Application (2021-2032)
Figure 26. North America Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 27. North America Mice Model Genetic Engineering Market Share by Type (2021-2032)
Figure 28. North America Mice Model Genetic Engineering Market Share by Application (2021-2032)
Figure 29. North America Mice Model Genetic Engineering Market Share by Country (2021-2032)
Figure 30. United States Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 31. Canada Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 32. Mexico Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 33. Europe Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 34. Europe Mice Model Genetic Engineering Market Share by Type (2021-2032)
Figure 35. Europe Mice Model Genetic Engineering Market Share by Application (2021-2032)
Figure 36. Europe Mice Model Genetic Engineering Market Share by Country (2021-2032)
Figure 37. Germany Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 38. France Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 39. U.K. Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 40. Italy Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 41. Russia Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 42. Nordic Countries Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 43. China Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 44. China Mice Model Genetic Engineering Market Share by Type (2021-2032)
Figure 45. China Mice Model Genetic Engineering Market Share by Application (2021-2032)
Figure 46. Asia Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 47. Asia Mice Model Genetic Engineering Market Share by Type (2021-2032)
Figure 48. Asia Mice Model Genetic Engineering Market Share by Application (2021-2032)
Figure 49. Asia Mice Model Genetic Engineering Market Share by Country (2021-2032)
Figure 50. Japan Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 51. South Korea Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 52. Taiwan Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 53. Southeast Asia Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 54. India Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 55. Australia Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 56. South America, Middle East & Africa Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 57. South America, Middle East & Africa Mice Model Genetic Engineering Market Share by Type (2021-2032)
Figure 58. South America, Middle East & Africa Mice Model Genetic Engineering Market Share by Application (2021-2032)
Figure 59. South America, Middle East & Africa Mice Model Genetic Engineering Market Share by Country (2021-2032)
Figure 60. Brazil Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 61. South Africa Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 62. Saudi Arabia Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 63. Turkey Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 64. Argentina Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 65. UAE Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 66. Egypt Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 67. Chile Mice Model Genetic Engineering Market Size (2021-2032) & (US$ Million)
Figure 68. Research Process
Figure 69. Key Executives Interviewed
Scope & coverage.
Types
- CRISPR Knockout
- CRISPR Knockin
- Random Insertions
- ES Cell Modification (homologous recombination)
- Others
Applications
- Pharmaceutical Companies
- Biotechnology Companies
- Academic & Research Facilities
- Contract Research & Manufacturing Organizations
Companies covered
- B BIOCYTOGEN
- Charles River Laboratories
- Cyagen Biosciences
- Gempharmatech
- genOway
- ingenious targeting laboratory
- Ozgene Pty Ltd.
- Taconic Biosciences, Inc.
- PolyGene AG
- THE JACKSON LABORATORY
- Yale School of Medicine
- University of North Carolina
- University of Nebraska Medical Center
- Monash University
- UMass Chan Medical School
- University of Bonn
- Columbia University
- The University of Arizona
- The Weizmann Institute of Science
- The Hebrew University of Jerusalem
- The Technion – Israel Institute of Technology
- Hadassah BrainLabs
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Mice Model Genetic Engineering Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 CRISPR Knockout
- 1.2.3 CRISPR Knockin
- 1.2.4 Random Insertions
- 1.2.5 ES Cell Modification (homologous recombination)
- 1.2.6 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Mice Model Genetic Engineering Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical Companies
- 1.3.3 Biotechnology Companies
- 1.3.4 Academic & Research Facilities
- 1.3.5 Contract Research & Manufacturing Organizations
- 1.4 Global Market Growth Prospects
- 1.5 Global Mice Model Genetic Engineering Growth Trends by Region
- 1.5.1 Global Mice Model Genetic Engineering Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Mice Model Genetic Engineering Market Size by Region (2021-2026)
- 1.5.3 Mice Model Genetic Engineering Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Mice Model Genetic Engineering Market Dynamics
- 2.1 Mice Model Genetic Engineering Industry Trends
- 2.2 Mice Model Genetic Engineering Industry Drivers
- 2.3 Mice Model Genetic Engineering Industry Opportunities and Challenges
- 2.4 Mice Model Genetic Engineering Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Mice Model Genetic Engineering Revenue by Company (2021-2026)
- 3.2 Global Mice Model Genetic Engineering Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Mice Model Genetic Engineering Key Company Head office and Area Served
- 3.4 Global Mice Model Genetic Engineering Company, Product Type & Application
- 3.5 Global Mice Model Genetic Engineering Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Mice Model Genetic Engineering Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Mice Model Genetic Engineering Players Market Share by Revenue in 2025
- 3.6.3 2025 Mice Model Genetic Engineering Tier 1, Tier 2, and Tier 3
4 Mice Model Genetic Engineering Market by Type
- 4.1 Global Mice Model Genetic Engineering Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Mice Model Genetic Engineering Market Size by Type (2021-2032)
- 4.3 Global Mice Model Genetic Engineering Market Size Share by Type (2021-2032)
5 Mice Model Genetic Engineering Market by Application
- 5.1 Global Mice Model Genetic Engineering Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Mice Model Genetic Engineering Market Size by Application (2021-2032)
- 5.3 Global Mice Model Genetic Engineering Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 B BIOCYTOGEN
- 6.1.1 B BIOCYTOGEN Company Information
- 6.1.2 B BIOCYTOGEN Business Overview
- 6.1.3 B BIOCYTOGEN Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 B BIOCYTOGEN Mice Model Genetic Engineering Product Portfolio
- 6.1.5 B BIOCYTOGEN Recent Developments
- 6.2 Charles River Laboratories
- 6.2.1 Charles River Laboratories Company Information
- 6.2.2 Charles River Laboratories Business Overview
- 6.2.3 Charles River Laboratories Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Charles River Laboratories Mice Model Genetic Engineering Product Portfolio
- 6.2.5 Charles River Laboratories Recent Developments
- 6.3 Cyagen Biosciences
- 6.3.1 Cyagen Biosciences Company Information
- 6.3.2 Cyagen Biosciences Business Overview
- 6.3.3 Cyagen Biosciences Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Cyagen Biosciences Mice Model Genetic Engineering Product Portfolio
- 6.3.5 Cyagen Biosciences Recent Developments
- 6.4 Gempharmatech
- 6.4.1 Gempharmatech Company Information
- 6.4.2 Gempharmatech Business Overview
- 6.4.3 Gempharmatech Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Gempharmatech Mice Model Genetic Engineering Product Portfolio
- 6.4.5 Gempharmatech Recent Developments
- 6.5 genOway
- 6.5.1 genOway Company Information
- 6.5.2 genOway Business Overview
- 6.5.3 genOway Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 genOway Mice Model Genetic Engineering Product Portfolio
- 6.5.5 genOway Recent Developments
- 6.6 ingenious targeting laboratory
- 6.6.1 ingenious targeting laboratory Company Information
- 6.6.2 ingenious targeting laboratory Business Overview
- 6.6.3 ingenious targeting laboratory Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 ingenious targeting laboratory Mice Model Genetic Engineering Product Portfolio
- 6.6.5 ingenious targeting laboratory Recent Developments
- 6.7 Ozgene Pty Ltd.
- 6.7.1 Ozgene Pty Ltd. Company Information
- 6.7.2 Ozgene Pty Ltd. Business Overview
- 6.7.3 Ozgene Pty Ltd. Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Ozgene Pty Ltd. Mice Model Genetic Engineering Product Portfolio
- 6.7.5 Ozgene Pty Ltd. Recent Developments
- 6.8 Taconic Biosciences, Inc.
- 6.8.1 Taconic Biosciences, Inc. Company Information
- 6.8.2 Taconic Biosciences, Inc. Business Overview
- 6.8.3 Taconic Biosciences, Inc. Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Taconic Biosciences, Inc. Mice Model Genetic Engineering Product Portfolio
- 6.8.5 Taconic Biosciences, Inc. Recent Developments
- 6.9 PolyGene AG
- 6.9.1 PolyGene AG Company Information
- 6.9.2 PolyGene AG Business Overview
- 6.9.3 PolyGene AG Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 PolyGene AG Mice Model Genetic Engineering Product Portfolio
- 6.9.5 PolyGene AG Recent Developments
- 6.10 THE JACKSON LABORATORY
- 6.10.1 THE JACKSON LABORATORY Company Information
- 6.10.2 THE JACKSON LABORATORY Business Overview
- 6.10.3 THE JACKSON LABORATORY Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 THE JACKSON LABORATORY Mice Model Genetic Engineering Product Portfolio
- 6.10.5 THE JACKSON LABORATORY Recent Developments
- 6.11 Yale School of Medicine
- 6.11.1 Yale School of Medicine Company Information
- 6.11.2 Yale School of Medicine Business Overview
- 6.11.3 Yale School of Medicine Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Yale School of Medicine Mice Model Genetic Engineering Product Portfolio
- 6.11.5 Yale School of Medicine Recent Developments
- 6.12 University of North Carolina
- 6.12.1 University of North Carolina Company Information
- 6.12.2 University of North Carolina Business Overview
- 6.12.3 University of North Carolina Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 University of North Carolina Mice Model Genetic Engineering Product Portfolio
- 6.12.5 University of North Carolina Recent Developments
- 6.13 University of Nebraska Medical Center
- 6.13.1 University of Nebraska Medical Center Company Information
- 6.13.2 University of Nebraska Medical Center Business Overview
- 6.13.3 University of Nebraska Medical Center Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 University of Nebraska Medical Center Mice Model Genetic Engineering Product Portfolio
- 6.13.5 University of Nebraska Medical Center Recent Developments
- 6.14 Monash University
- 6.14.1 Monash University Company Information
- 6.14.2 Monash University Business Overview
- 6.14.3 Monash University Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Monash University Mice Model Genetic Engineering Product Portfolio
- 6.14.5 Monash University Recent Developments
- 6.15 UMass Chan Medical School
- 6.15.1 UMass Chan Medical School Company Information
- 6.15.2 UMass Chan Medical School Business Overview
- 6.15.3 UMass Chan Medical School Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 UMass Chan Medical School Mice Model Genetic Engineering Product Portfolio
- 6.15.5 UMass Chan Medical School Recent Developments
- 6.16 University of Bonn
- 6.16.1 University of Bonn Company Information
- 6.16.2 University of Bonn Business Overview
- 6.16.3 University of Bonn Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 University of Bonn Mice Model Genetic Engineering Product Portfolio
- 6.16.5 University of Bonn Recent Developments
- 6.17 Columbia University
- 6.17.1 Columbia University Company Information
- 6.17.2 Columbia University Business Overview
- 6.17.3 Columbia University Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Columbia University Mice Model Genetic Engineering Product Portfolio
- 6.17.5 Columbia University Recent Developments
- 6.18 The University of Arizona
- 6.18.1 The University of Arizona Company Information
- 6.18.2 The University of Arizona Business Overview
- 6.18.3 The University of Arizona Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 The University of Arizona Mice Model Genetic Engineering Product Portfolio
- 6.18.5 The University of Arizona Recent Developments
- 6.19 The Weizmann Institute of Science
- 6.19.1 The Weizmann Institute of Science Company Information
- 6.19.2 The Weizmann Institute of Science Business Overview
- 6.19.3 The Weizmann Institute of Science Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.19.4 The Weizmann Institute of Science Mice Model Genetic Engineering Product Portfolio
- 6.19.5 The Weizmann Institute of Science Recent Developments
- 6.20 The Hebrew University of Jerusalem
- 6.20.1 The Hebrew University of Jerusalem Company Information
- 6.20.2 The Hebrew University of Jerusalem Business Overview
- 6.20.3 The Hebrew University of Jerusalem Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.20.4 The Hebrew University of Jerusalem Mice Model Genetic Engineering Product Portfolio
- 6.20.5 The Hebrew University of Jerusalem Recent Developments
- 6.21 The Technion – Israel Institute of Technology
- 6.21.1 The Technion – Israel Institute of Technology Company Information
- 6.21.2 The Technion – Israel Institute of Technology Business Overview
- 6.21.3 The Technion – Israel Institute of Technology Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.21.4 The Technion – Israel Institute of Technology Mice Model Genetic Engineering Product Portfolio
- 6.21.5 The Technion – Israel Institute of Technology Recent Developments
- 6.22 Hadassah BrainLabs
- 6.22.1 Hadassah BrainLabs Company Information
- 6.22.2 Hadassah BrainLabs Business Overview
- 6.22.3 Hadassah BrainLabs Mice Model Genetic Engineering Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.22.4 Hadassah BrainLabs Mice Model Genetic Engineering Product Portfolio
- 6.22.5 Hadassah BrainLabs Recent Developments
7 North America
- 7.1 North America Mice Model Genetic Engineering Market Size (2021-2032)
- 7.2 North America Mice Model Genetic Engineering Market Size by Type
- 7.2.1 North America Mice Model Genetic Engineering Market Size by Type (2021-2026)
- 7.2.2 North America Mice Model Genetic Engineering Market Size by Type (2027-2032)
- 7.2.3 North America Mice Model Genetic Engineering Market Share by Type (2021-2032)
- 7.3 North America Mice Model Genetic Engineering Market Size by Application
- 7.3.1 North America Mice Model Genetic Engineering Market Size by Application (2021-2026)
- 7.3.2 North America Mice Model Genetic Engineering Market Size by Application (2027-2032)
- 7.3.3 North America Mice Model Genetic Engineering Market Share by Application (2021-2032)
- 7.4 North America Mice Model Genetic Engineering Market Size by Country
- 7.4.1 North America Mice Model Genetic Engineering Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Mice Model Genetic Engineering Market Size by Country (2021-2026)
- 7.4.3 North America Mice Model Genetic Engineering Market Size by Country (2027-2032)
- 7.4.4 North America Mice Model Genetic Engineering Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Mice Model Genetic Engineering Market Size (2021-2032)
- 8.2 Europe Mice Model Genetic Engineering Market Size by Type
- 8.2.1 Europe Mice Model Genetic Engineering Market Size by Type (2021-2026)
- 8.2.2 Europe Mice Model Genetic Engineering Market Size by Type (2027-2032)
- 8.2.3 Europe Mice Model Genetic Engineering Market Share by Type (2021-2032)
- 8.3 Europe Mice Model Genetic Engineering Market Size by Application
- 8.3.1 Europe Mice Model Genetic Engineering Market Size by Application (2021-2026)
- 8.3.2 Europe Mice Model Genetic Engineering Market Size by Application (2027-2032)
- 8.3.3 Europe Mice Model Genetic Engineering Market Share by Application (2021-2032)
- 8.4 Europe Mice Model Genetic Engineering Market Size by Country
- 8.4.1 Europe Mice Model Genetic Engineering Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Mice Model Genetic Engineering Market Size by Country (2021-2026)
- 8.4.3 Europe Mice Model Genetic Engineering Market Size by Country (2027-2032)
- 8.4.4 Europe Mice Model Genetic Engineering Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Mice Model Genetic Engineering Market Size (2021-2032)
- 9.2 China Mice Model Genetic Engineering Market Size by Type
- 9.2.1 China Mice Model Genetic Engineering Market Size by Type (2021-2026)
- 9.2.2 China Mice Model Genetic Engineering Market Size by Type (2027-2032)
- 9.2.3 China Mice Model Genetic Engineering Market Share by Type (2021-2032)
- 9.3 China Mice Model Genetic Engineering Market Size by Application
- 9.3.1 China Mice Model Genetic Engineering Market Size by Application (2021-2026)
- 9.3.2 China Mice Model Genetic Engineering Market Size by Application (2027-2032)
- 9.3.3 China Mice Model Genetic Engineering Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Mice Model Genetic Engineering Market Size (2021-2032)
- 10.2 Asia Mice Model Genetic Engineering Market Size by Type
- 10.2.1 Asia Mice Model Genetic Engineering Market Size by Type (2021-2026)
- 10.2.2 Asia Mice Model Genetic Engineering Market Size by Type (2027-2032)
- 10.2.3 Asia Mice Model Genetic Engineering Market Share by Type (2021-2032)
- 10.3 Asia Mice Model Genetic Engineering Market Size by Application
- 10.3.1 Asia Mice Model Genetic Engineering Market Size by Application (2021-2026)
- 10.3.2 Asia Mice Model Genetic Engineering Market Size by Application (2027-2032)
- 10.3.3 Asia Mice Model Genetic Engineering Market Share by Application (2021-2032)
- 10.4 Asia Mice Model Genetic Engineering Market Size by Country
- 10.4.1 Asia Mice Model Genetic Engineering Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Mice Model Genetic Engineering Market Size by Country (2021-2026)
- 10.4.3 Asia Mice Model Genetic Engineering Market Size by Country (2027-2032)
- 10.4.4 Asia Mice Model Genetic Engineering Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Mice Model Genetic Engineering Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Mice Model Genetic Engineering Market Size by Type
- 11.2.1 South America, Middle East & Africa Mice Model Genetic Engineering Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Mice Model Genetic Engineering Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Mice Model Genetic Engineering Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Mice Model Genetic Engineering Market Size by Application
- 11.3.1 South America, Middle East & Africa Mice Model Genetic Engineering Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Mice Model Genetic Engineering Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Mice Model Genetic Engineering Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Mice Model Genetic Engineering Market Size by Country
- 11.4.1 South America, Middle East & Africa Mice Model Genetic Engineering Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Mice Model Genetic Engineering Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Mice Model Genetic Engineering Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Mice Model Genetic Engineering Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst